ISIN | CH0009699411 |
---|---|
Valor Number | 969941 |
Bloomberg Global ID | |
Fund Name | Unigestion Swiss Equities A |
Fund Provider |
Unigestion
Genève 12, Switzerland Phone: +41 22 704 41 11 Web: www.unigestion.com |
Fund Provider | Unigestion |
Representative in Switzerland | |
Distributor(s) |
Unigestion S.A. Genève 12 Phone: +41 22 704 41 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | The main objective of the fund is to achieve a long term performance equal to,or greater than,the SMI index,with a lower volatility while controlling the tracking error of the portfolio.This is achieved by using a quantitative method based on the construction of a "minimum variance" portfolio,i.e. the optimal portfolio having the lowest expected volatility or risk. |
Peculiarities |
Current Price * | 2,516.09 CHF | 16.12.2024 |
---|---|---|
Previous Price * | 2,515.81 CHF | 13.12.2024 |
52 Week High * | 2,595.36 CHF | 18.10.2024 |
52 Week Low * | 2,304.98 CHF | 09.02.2024 |
NAV * | 2,516.09 CHF | 16.12.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 81,484,157 | |
Unit/Share Assets *** | 2,582,217 | |
Trading Information SIX |
YTD Performance | +7.78% |
29.12.2023 - 16.12.2024
29.12.2023 16.12.2024 |
---|---|---|
1 month | +0.66% |
18.11.2024 - 16.12.2024
18.11.2024 16.12.2024 |
3 months | -0.52% |
16.09.2024 - 16.12.2024
16.09.2024 16.12.2024 |
6 months | +1.16% |
17.06.2024 - 16.12.2024
17.06.2024 16.12.2024 |
1 year | +7.43% |
18.12.2023 - 16.12.2024
18.12.2023 16.12.2024 |
2 years | +9.00% |
16.12.2022 - 16.12.2024
16.12.2022 16.12.2024 |
3 years | -4.98% |
17.12.2021 - 16.12.2024
17.12.2021 16.12.2024 |
5 years | +12.75% |
16.12.2019 - 16.12.2024
16.12.2019 16.12.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 11.34% | |
---|---|---|
Roche Holding AG | 10.82% | |
Nestle SA | 9.41% | |
Zurich Insurance Group AG | 7.75% | |
Swiss Re AG | 4.98% | |
ABB Ltd | 4.84% | |
Swisscom AG | 3.75% | |
Swiss Prime Site AG | 3.43% | |
PSP Swiss Property AG | 3.31% | |
UBS Group AG | 3.19% | |
Last data update | 31.10.2024 |
TER | 1.36% |
---|---|
TER date | 31.03.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.30% |
Ongoing Charges *** | 1.36% |
SRRI ***
|
|
SRRI date *** | 30.11.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |